Correlation between the expression of DNMT1, and GSTP1 and APC, and the methylation status of GSTP1 and APC in association with their clinical significance in prostate cancer

Molecular Medicine Reports

Volumn 12, Issue 1, 2015, Pages 141-146

  Zhang, Weijie ^a   Jiao, Hongliang ^a   Zhang, Xudong ^a   Zhao, Ruihua ^a   Wang, Feng ^a   He, Wei ^a   Zong, Hong ^a   Fan, Qingxia ^a   Wang, Liuxing ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Adenomatous polyposis coli; Benign prostatic hyperplasia; DNA (cytosine 5) methyltransferase 1; Glutathione S transferase P1; Methylation; Prostate cancer

Indexed keywords

APC PROTEIN; DNA METHYLTRANSFERASE 1; GLUTATHIONE TRANSFERASE P1; APC PROTEIN, HUMAN; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; GSTP1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; CYTOPLASM; DNA METHYLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; VERY ELDERLY; BIOSYNTHESIS; CANCER STAGING; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR;

ADENOMATOUS POLYPOSIS COLI PROTEIN; AGED; AGED, 80 AND OVER; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE S-TRANSFERASE PI; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 84926626740     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3402     Document Type: Article

References (25)

1. Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin 65: 5-29, 2015.
2. Rodriquez C, Calle EE, Miracle-McMahill HL, Tatham LM, Wingo PA, Thun MJ and Heath CW Jr: Family history and risk of fatal prostate cancer. Epidemiology 8: 653-657, 1997.
3. Neugut AI, Chen AC and Petrylak DP: The skinny on obesity and prostate cancer prognosis. J Clin Oncol 22: 395-398, 2004.
4. Esteller M, Corn PG, Baylin SB and Herman JG: A gene hypermethylation profile of human cancer. Cancer Res 61: 3225-3229, 2001.
5. Li LC, Okino ST and Dahiya R: DNA methylation in prostate cancer. Biochim Biophys Acta 1704: 87-102, 2004.
6. Richiardi L, Fiano V, Vizzini L, De Marco L, Delsedime L, Akre O, Tos AG and Merletti F: Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients. J Clin Oncol 27: 3161-3168, 2009.
7. Kang GH, Lee S, Lee H, Hwang J and Aberrant KS: CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial. Neoplasia J Pathol 202: 233-240, 2004.
8. Phé V, Cussenot O and Rouprêt M: Methylated genes as potential biomarkers in prostate cancer. BJU Int 105: 1364-1370, 2010.
9. Yoder JA, Walsh CP and Bestor TH: Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 13: 335-340, 1997.
10. Bird AP: CpG-rich islands and the function of DNA methylation. Nature 321: 209-213, 1986.
11. Gardiner-Garden M and Frommer M: CpG islands in vertebrate genomes. J Mol Biol 196: 261-282, 1987.
12. Baylin SB and Ohm JE: Epigenetic gene silencing in cancer-A mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6: 107-116, 2006.
13. Ross SA: Diet and DNA methylation interactions in cancer prevention. Ann NY Acad Sci 983: 197-207, 2003.
14. Brenner C and Fuks F: DNA methyltransferases: facts, clue, mysteries. Curr Top Microbiol Immunol 301: 45-66, 2006.
15. Gopisetty G, Ramachandran K and Singal R: DNA methylation and apoptosis. Mol Immunol 43: 1729-1740, 2006.
16. Singal R and Ginder GD: DNA methylation. Blood 93: 4059-4070, 1999.
17. Berhane K, Widersten M, Engstrom A, Kozarich JW and Mannervik B: Detoxication of base propenals and other alpha, betaunsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc Natl Acad Sci USA 91: 1480-1484, 1994.
18. Nelson CP, Kidd LC, Sauvageot J, Isaacs WB, De Marzo AM, Groopman JD, Nelson WG and Kensler TW: Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. Cancer Res 61: 103-109, 2001.
19. Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Hsieh WS, Isaacs WB and Nelson WG: Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 91: 11733-11737, 1994.
20. Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, Epstein JI, Isaacs WB and Nelson WG: CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomark Prev 7: 531-536, 1998.
21. Nakayama M, Bennett CJ, Hicks JL, Epstein JI, Platz EA, Nelson WG and De Marzo AM: Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. Am J Pathol 163: 923-933, 2003.
22. Lin X, Tascilar M, Lee WH, et al: GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol 159: 1815-1826, 2001.
23. Thliveris A, Albertsen H, Tuohy T, Carlson M, Groden J, Joslyn G, Gelbert L, Samowitz W, Spirio L and White R: Long-range physical map and deletion characterization of the 1100-kb NotI restriction fragment harboring the APC gene. Genomics 34: 268-270, 1996.
24. Fearnhead NS, Britton MP and Bodmer WF: The ABC of APC. Hum Mol Genet 10: 721-733, 2001.
25. Woodson K, O'Reilly KJ, Hanson JC, et al: The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer. J Urol 179: 508-511, 2008.